Aurobindo Pharma Ltd. (AUROPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 164981,
    "name": "Aurobindo Pharma",
    "stock_name": "Aurobindo Pharma",
    "full_name": "Aurobindo Pharma Ltd.",
    "name_url": "stocks-analysis/aurobindo-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,308.00",
    "chg": 26.75,
    "chgp": "2.09%",
    "dir": 1,
    "prev_price": "1,281.25",
    "mcapval": "75,028.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524804,
    "symbol": "AUROPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE406A01037",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "30.01 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1320.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-of-rs-13204-3916018",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AurobindoPharma_priceRelatedfactors_3916018.png",
        "date": "2026-03-25 10:40:40",
        "description": "With a decisive surge to Rs 1320.4 on 25 Mar 2026, Aurobindo Pharma Ltd. has reached a fresh 52-week high, outperforming its sector and demonstrating robust technical momentum across multiple timeframes."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amidst Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amidst-mixed-market-signals-3910749",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AurobindoPharma_oi_spurts_by_underlying_3910749.png",
        "date": "2026-03-24 15:00:08",
        "description": "Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 17.75% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest 0.16% gain in the stock price, the underlying dynamics suggest a complex interplay of bullish and cautious bets as the stock trades close to its 52-week high."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amidst Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amidst-mixed-market-signals-3910633",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AurobindoPharma_oi_spurts_by_underlying_3910633.png",
        "date": "2026-03-24 14:00:09",
        "description": "Aurobindo Pharma Ltd. has witnessed a significant 15.96% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite trading close to its 52-week high, the stock’s recent underperformance relative to its sector and the broader Sensex suggests a complex interplay of bullish and cautious sentiment among traders."
      },
      {
        "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3908962",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AurobindoPharma_technicaldot_3908962.png",
        "date": "2026-03-24 08:00:26",
        "description": "Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in the share price, the stock continues to demonstrate resilience against broader market declines, supported by a complex interplay of technical indicators such as MACD, RSI, Bollinger Bands, and moving averages."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-bullish-market-positioning-3908203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AurobindoPharma_oi_spurts_by_underlying_3908203.png",
        "date": "2026-03-23 15:00:05",
        "description": "Aurobindo Pharma Ltd. has witnessed a significant 27.8% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 1.07% decline in its share price on 23 Mar 2026, the pharmaceutical giant’s futures and options volumes suggest a complex interplay of bullish and cautious bets amid a broader sector downturn."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amidst Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amidst-mixed-market-signals-3907786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AurobindoPharma_oi_spurts_by_underlying_3907786.png",
        "date": "2026-03-23 14:00:05",
        "description": "Aurobindo Pharma Ltd. has witnessed a significant 21.4% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest decline in its share price, the pharmaceutical mid-cap continues to trade near its 52-week high, outperforming its sector amid a broader market downturn."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-3907670",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AurobindoPharma_oi_spurts_by_underlying_3907670.png",
        "date": "2026-03-23 13:00:04",
        "description": "Aurobindo Pharma Ltd. has witnessed a significant 18.7% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 1.04% decline in the stock price on 23 Mar 2026, the pharmaceutical company’s futures and options volumes have surged, reflecting a complex interplay of bullish and bearish bets amid a broader sector downturn."
      },
      {
        "title": "Aurobindo Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-significant-open-interest-surge-amid-mixed-market-signals-3907104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AurobindoPharma_oi_spurts_by_underlying_3907104.png",
        "date": "2026-03-23 12:00:05",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable surge in open interest in its derivatives segment, with an 11.76% increase signalling heightened market activity and shifting investor positioning. Despite a slight dip in the stock price, the pharmaceutical company’s futures and options volumes suggest a complex interplay of bullish and cautious bets amid broader sector weakness."
      },
      {
        "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-market-volatility-3906172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AurobindoPharma_technicaldot_3906172.png",
        "date": "2026-03-23 08:00:13",
        "description": "Aurobindo Pharma Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by positive signals from key technical indicators such as the MACD and moving averages, despite mixed readings from other momentum oscillators. The stock’s recent price action, combined with its relative performance against the Sensex, suggests a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 760,
    "sid": "164981",
    "stock_news_url": "https://www.marketsmojo.com/news/aurobindo-pharma-164981"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Mar-2026",
      "details": "Intimation of closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Classification Of Unit-V Of Apitoria Pharma Limited A Wholly Owned Subsidiary Of The Company As VAI By The US FDA",
      "datetime": "20-Mar-2026",
      "details": "Intimation of classification of Unit-V of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company as VAI by the US FDA.",
      "source": "BSE"
    },
    {
      "caption": "Classification Of Unit-II Of Eugia Pharma Specialities Limited A Wholly Owned Subsidiary Of The Company As OAI By The US FDA",
      "datetime": "17-Mar-2026",
      "details": "Intimation of classification of Unit-II of Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company as OAI by the US FDA.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11",
          "dt": "2011-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15",
          "dt": "2015-07-20",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1320.4

2026-03-25 10:40:40

With a decisive surge to Rs 1320.4 on 25 Mar 2026, Aurobindo Pharma Ltd. has reached a fresh 52-week high, outperforming its sector and demonstrating robust technical momentum across multiple timeframes.

Read full news article

Aurobindo Pharma Sees Sharp Open Interest Surge Amidst Mixed Market Signals

2026-03-24 15:00:08

Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 17.75% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest 0.16% gain in the stock price, the underlying dynamics suggest a complex interplay of bullish and cautious bets as the stock trades close to its 52-week high.

Read full news article

Aurobindo Pharma Sees Sharp Open Interest Surge Amidst Mixed Market Signals

2026-03-24 14:00:09

Aurobindo Pharma Ltd. has witnessed a significant 15.96% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite trading close to its 52-week high, the stock’s recent underperformance relative to its sector and the broader Sensex suggests a complex interplay of bullish and cautious sentiment among traders.

Read full news article

Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-03-24 08:00:26

Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in the share price, the stock continues to demonstrate resilience against broader market declines, supported by a complex interplay of technical indicators such as MACD, RSI, Bollinger Bands, and moving averages.

Read full news article

Aurobindo Pharma Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-03-23 15:00:05

Aurobindo Pharma Ltd. has witnessed a significant 27.8% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 1.07% decline in its share price on 23 Mar 2026, the pharmaceutical giant’s futures and options volumes suggest a complex interplay of bullish and cautious bets amid a broader sector downturn.

Read full news article

Aurobindo Pharma Sees Sharp Open Interest Surge Amidst Mixed Market Signals

2026-03-23 14:00:05

Aurobindo Pharma Ltd. has witnessed a significant 21.4% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest decline in its share price, the pharmaceutical mid-cap continues to trade near its 52-week high, outperforming its sector amid a broader market downturn.

Read full news article

Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-23 13:00:04

Aurobindo Pharma Ltd. has witnessed a significant 18.7% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 1.04% decline in the stock price on 23 Mar 2026, the pharmaceutical company’s futures and options volumes have surged, reflecting a complex interplay of bullish and bearish bets amid a broader sector downturn.

Read full news article

Aurobindo Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-03-23 12:00:05

Aurobindo Pharma Ltd. has witnessed a notable surge in open interest in its derivatives segment, with an 11.76% increase signalling heightened market activity and shifting investor positioning. Despite a slight dip in the stock price, the pharmaceutical company’s futures and options volumes suggest a complex interplay of bullish and cautious bets amid broader sector weakness.

Read full news article

Aurobindo Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility

2026-03-23 08:00:13

Aurobindo Pharma Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by positive signals from key technical indicators such as the MACD and moving averages, despite mixed readings from other momentum oscillators. The stock’s recent price action, combined with its relative performance against the Sensex, suggests a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News